BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:33 PM
 | 
Sep 07, 2012
 |  BC Extra  |  Company News

SFJ, Pfizer in deal for NSCLC product

SFJ Pharmaceuticals Inc. (Pleasanton, Calif.) agreed to fund and conduct a Phase III trial of dacomitinib from Pfizer Inc. (NYSE:PFE) in exchange for potential milestones and royalties tied to...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >